Posted by
Always To The Right on Thursday, August 13, 2009 5:07:16 PM
Why would the pharmaceutical business risk
creating a monopsony among its consumer base by supporting a government
program that could eventually lead to a single-payer system? Having
only one client — especially a client with the power to regulate the
price you can charge him — gives him an awful lot of leverage over you.
Which is, er, a bad thing, isn’t it? Yet they’re ready to plunk down
$150 million to advertise on behalf of it, on the word of a guy from
Chicago that he won’t double-cross them and demand lower prices once
the bill is safely passed and he has the power he wants. Good work,
pharma.